首页 > 最新文献

JAMA facial plastic surgery最新文献

英文 中文
Advances in Face-lift Techniques, 2013-2018: A Systematic Review. 2013-2018年整容技术进展综述
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2018.1472
Elizabeth M Floyd, Daniel C Sukato, Stephen W Perkins

Importance: Rhytidectomy, or face-lift surgery, is the mainstay of facial rejuvenation and is constantly evolving. There is continuous research to improve outcomes and minimize complications of this surgery.

Objective: To synthesize the updated techniques in rhytidectomy published during the past 5 years, including surgical technique, advances in anesthetic technique, minimally invasive techniques, and adjunctive procedures performed at the time of rhytidectomy.

Evidence review: On February 8, 2018, a literature search was performed of the PubMed and Cochrane databases using the search terms, face-lift or rhytidectomy and techniques. Articles published from February 8, 2013, to February 8, 2018, that related to techniques of facial rejuvenation in the lower one-third of the face by lifting and supporting tissue with 5 or more patients were included. Systematic reviews and primary literature were considered; narrative reviews, validation studies, and anatomic studies were eliminated. The initial search resulted in 604 articles after duplicates were removed. This was reduced to 84 articles after dual independent review screening.

Findings: Of the 84 articles included, 51 (61%) regarding techniques of face-lifting in the past 5 years pertained to soft-tissue techniques; 14 (17%) pertained to implants or adjunctive medications, such as tissue sealants; and 12 (14%) related to adjunctive techniques performed in addition to face-lifting, such as fat grafting, resurfacing, and liposuction. All studies found the techniques reported therein to be effective, with similar or fewer complications compared with the literature. However, according to the Oxford Centre for Evidence-Based Medicine criteria, the level of evidence of the studies was generally poor, because 45 of the studies (54%) were case series (level 4 of evidence).

Conclusions and relevance: Several new techniques have been explored for rhytidectomy or face-lift in the past 5 years, including soft-tissue techniques, introduction of implants or topical medications such as tissue sealants, and concomitant adjunctive techniques to enhance results. The overall quality of the evidence is poor, with most articles using case series with nonvalidated measures to evaluate outcomes. There is considerable room for improvement in the literature if additional studies using cohort designs and validated outcomes are performed to validate the quality of the techniques introduced during the past 5 years.

重要性:除皱手术或面部拉皮手术是面部年轻化的主要方法,并在不断发展。有持续的研究,以改善结果和减少并发症的手术。目的:综合近5年来发表的除皱技术的最新进展,包括手术技术、麻醉技术进展、微创技术和除皱时的辅助技术。证据回顾:2018年2月8日,我们在PubMed和Cochrane数据库中检索了相关文献,检索词为face-lift or rhytidectomy和techniques。2013年2月8日至2018年2月8日发表的文章,涉及5名或以上患者通过提升和支撑组织在面部下三分之一的面部年轻化技术。考虑了系统综述和原始文献;叙述性综述、验证性研究和解剖学研究被排除。最初的搜索结果是删除重复后的604篇文章。经过双重独立审查筛选后,减少到84篇。研究结果:在纳入的84篇文章中,51篇(61%)涉及过去5年的整容技术,涉及软组织技术;14例(17%)涉及植入物或辅助药物,如组织密封剂;12例(14%)与除面部提升术外的辅助技术有关,如脂肪移植、表面重塑和吸脂。所有的研究都发现其中报道的技术是有效的,与文献相比并发症相似或更少。然而,根据牛津循证医学标准中心,这些研究的证据水平普遍较差,因为45项研究(54%)是病例系列(证据水平4)。结论和相关性:在过去的5年里,一些新的技术被用于除皱或面部提升,包括软组织技术,植入物或局部药物(如组织密封剂)的引入,以及伴随的辅助技术来提高效果。证据的总体质量较差,大多数文章使用未经验证的措施来评估结果的病例系列。如果使用队列设计和验证结果进行额外的研究来验证过去5年中引入的技术的质量,则文献中有相当大的改进空间。
{"title":"Advances in Face-lift Techniques, 2013-2018: A Systematic Review.","authors":"Elizabeth M Floyd,&nbsp;Daniel C Sukato,&nbsp;Stephen W Perkins","doi":"10.1001/jamafacial.2018.1472","DOIUrl":"https://doi.org/10.1001/jamafacial.2018.1472","url":null,"abstract":"<p><strong>Importance: </strong>Rhytidectomy, or face-lift surgery, is the mainstay of facial rejuvenation and is constantly evolving. There is continuous research to improve outcomes and minimize complications of this surgery.</p><p><strong>Objective: </strong>To synthesize the updated techniques in rhytidectomy published during the past 5 years, including surgical technique, advances in anesthetic technique, minimally invasive techniques, and adjunctive procedures performed at the time of rhytidectomy.</p><p><strong>Evidence review: </strong>On February 8, 2018, a literature search was performed of the PubMed and Cochrane databases using the search terms, face-lift or rhytidectomy and techniques. Articles published from February 8, 2013, to February 8, 2018, that related to techniques of facial rejuvenation in the lower one-third of the face by lifting and supporting tissue with 5 or more patients were included. Systematic reviews and primary literature were considered; narrative reviews, validation studies, and anatomic studies were eliminated. The initial search resulted in 604 articles after duplicates were removed. This was reduced to 84 articles after dual independent review screening.</p><p><strong>Findings: </strong>Of the 84 articles included, 51 (61%) regarding techniques of face-lifting in the past 5 years pertained to soft-tissue techniques; 14 (17%) pertained to implants or adjunctive medications, such as tissue sealants; and 12 (14%) related to adjunctive techniques performed in addition to face-lifting, such as fat grafting, resurfacing, and liposuction. All studies found the techniques reported therein to be effective, with similar or fewer complications compared with the literature. However, according to the Oxford Centre for Evidence-Based Medicine criteria, the level of evidence of the studies was generally poor, because 45 of the studies (54%) were case series (level 4 of evidence).</p><p><strong>Conclusions and relevance: </strong>Several new techniques have been explored for rhytidectomy or face-lift in the past 5 years, including soft-tissue techniques, introduction of implants or topical medications such as tissue sealants, and concomitant adjunctive techniques to enhance results. The overall quality of the evidence is poor, with most articles using case series with nonvalidated measures to evaluate outcomes. There is considerable room for improvement in the literature if additional studies using cohort designs and validated outcomes are performed to validate the quality of the techniques introduced during the past 5 years.</p>","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"252-259"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2018.1472","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36840803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Comparison of Micro-Computed Tomography and Clinical Computed Tomography Protocols for Visualization of Nasal Cartilage Before Surgical Planning for Rhinoplasty. 鼻成形术计划前鼻软骨可视化的显微计算机断层扫描与临床计算机断层扫描的比较。
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2018.1931
Rajeev C Saxena, Seth Friedman, Randall A Bly, Jeffrey Otjen, Adam M Alessio, Yangming Li, Blake Hannaford, Mark Whipple, Kris S Moe

Importance: There is no imaging standard to model nasal cartilage for the planning of rhinoplasty procedures. Preoperative visualization of cartilage may improve objective evaluation of nasal deformities, surgical planning, and surgical reconstruction.

Objectives: To evaluate the feasibility of visualizing nasal cartilage using high resolution micro-computed tomography (CT) compared with the criterion standard of pathologic findings in a cadaveric specimen and to evaluate its accuracy compared with various clinical CT protocols.

Design, setting, and participants: Anatomic study at the University of Washington using single human cadaveric nasal specimens performed from July 10, 2017, to March 30, 2018.

Interventions: A micro-CT acquisition with 60-micron resolution was obtained of a nasal specimen. The specimen was then scanned with 5 different clinical CT protocols to span both clinical care and machine limits. The specimen was then sectioned in 5-mm axial slices for pathologic analysis.

Main outcomes and measures: Micro-CT images were registered to pathologic specimen cross-sections using a graphite fiducial system. Cartilage substructures were manually segmented and analyzed. A library of matched images across the micro-CT and various clinical CT protocols was then developed. Region of interest analysis was performed for each of the cartilage structures and their boundaries on clinical CT protocols and micro-CT, with the outcome of mean (SD) density using Hounsfield units.

Results: A single human cadaveric nasal specimen was used to obtain the following results. Lower lateral cartilage, upper lateral cartilage, and septal cartilage were accurately delineated on the micro-CT images compared with pathologic findings. The mean absolute deviation from pathologic findings was 0.30 mm for septal cartilage thickness, 0.98 mm for maximal upper lateral cartilage length, and 1.40 mm for maximal lower lateral cartilage length. On clinical CT protocols, only septal cartilage was well discriminated from boundary. Higher radiation dose resulted in more accurate density measurements of cartilage, but it did not ultimately improve ability to discriminate cartilage.

Conclusions and relevance: The results of this anatomic study may represent a notable step toward advancing knowledge of the capabilities and pitfalls of nasal cartilage visualization on CT. Nasal cartilage visualization was feasible on the micro-CT compared with pathologic findings. Future research may further examine the barriers to accurately visualizing upper lateral cartilage and lower lateral cartilage, a prerequisite for clinical application.

Level of evidence: NA.

重要性:没有影像学标准来模拟鼻软骨来规划鼻整形手术。术前软骨可视化可以改善鼻畸形的客观评估、手术计划和手术重建。目的:评价高分辨率显微计算机断层扫描(CT)在鼻软骨成像中的可行性,并将其与尸体标本病理表现的标准进行比较,评价其与各种临床CT方案的准确性。设计、环境和参与者:华盛顿大学的解剖学研究使用了2017年7月10日至2018年3月30日进行的单个人类尸体鼻腔标本。干预措施:获得60微米分辨率的鼻腔标本显微ct采集。然后用5种不同的临床CT方案扫描标本,以跨越临床护理和机器限制。然后将标本切成5毫米轴向切片进行病理分析。主要结果和措施:使用石墨基准系统将显微ct图像注册到病理标本的横截面上。人工对软骨亚结构进行分割和分析。然后开发了微型CT和各种临床CT协议的匹配图像库。在临床CT和微型CT上对每个软骨结构及其边界进行感兴趣区域分析,并使用Hounsfield单位计算平均(SD)密度。结果:用单个人尸体鼻标本得到以下结果。下外侧软骨、上外侧软骨和中隔软骨在显微ct图像上与病理表现比较准确。中隔软骨厚度与病理结果的平均绝对偏差为0.30 mm,最大上外侧软骨长度为0.98 mm,最大下外侧软骨长度为1.40 mm。在临床CT上,仅隔软骨与边界区分较好。较高的辐射剂量导致更精确的软骨密度测量,但它并没有最终提高区分软骨的能力。结论和相关性:本解剖研究的结果可能代表了一个显著的一步,以提高知识的能力和陷阱的鼻软骨在CT上的可视化。鼻软骨在微ct上的显示与病理表现相比是可行的。未来的研究可能会进一步研究准确显示上外侧软骨和下外侧软骨的障碍,这是临床应用的先决条件。证据等级:NA。
{"title":"Comparison of Micro-Computed Tomography and Clinical Computed Tomography Protocols for Visualization of Nasal Cartilage Before Surgical Planning for Rhinoplasty.","authors":"Rajeev C Saxena,&nbsp;Seth Friedman,&nbsp;Randall A Bly,&nbsp;Jeffrey Otjen,&nbsp;Adam M Alessio,&nbsp;Yangming Li,&nbsp;Blake Hannaford,&nbsp;Mark Whipple,&nbsp;Kris S Moe","doi":"10.1001/jamafacial.2018.1931","DOIUrl":"https://doi.org/10.1001/jamafacial.2018.1931","url":null,"abstract":"<p><strong>Importance: </strong>There is no imaging standard to model nasal cartilage for the planning of rhinoplasty procedures. Preoperative visualization of cartilage may improve objective evaluation of nasal deformities, surgical planning, and surgical reconstruction.</p><p><strong>Objectives: </strong>To evaluate the feasibility of visualizing nasal cartilage using high resolution micro-computed tomography (CT) compared with the criterion standard of pathologic findings in a cadaveric specimen and to evaluate its accuracy compared with various clinical CT protocols.</p><p><strong>Design, setting, and participants: </strong>Anatomic study at the University of Washington using single human cadaveric nasal specimens performed from July 10, 2017, to March 30, 2018.</p><p><strong>Interventions: </strong>A micro-CT acquisition with 60-micron resolution was obtained of a nasal specimen. The specimen was then scanned with 5 different clinical CT protocols to span both clinical care and machine limits. The specimen was then sectioned in 5-mm axial slices for pathologic analysis.</p><p><strong>Main outcomes and measures: </strong>Micro-CT images were registered to pathologic specimen cross-sections using a graphite fiducial system. Cartilage substructures were manually segmented and analyzed. A library of matched images across the micro-CT and various clinical CT protocols was then developed. Region of interest analysis was performed for each of the cartilage structures and their boundaries on clinical CT protocols and micro-CT, with the outcome of mean (SD) density using Hounsfield units.</p><p><strong>Results: </strong>A single human cadaveric nasal specimen was used to obtain the following results. Lower lateral cartilage, upper lateral cartilage, and septal cartilage were accurately delineated on the micro-CT images compared with pathologic findings. The mean absolute deviation from pathologic findings was 0.30 mm for septal cartilage thickness, 0.98 mm for maximal upper lateral cartilage length, and 1.40 mm for maximal lower lateral cartilage length. On clinical CT protocols, only septal cartilage was well discriminated from boundary. Higher radiation dose resulted in more accurate density measurements of cartilage, but it did not ultimately improve ability to discriminate cartilage.</p><p><strong>Conclusions and relevance: </strong>The results of this anatomic study may represent a notable step toward advancing knowledge of the capabilities and pitfalls of nasal cartilage visualization on CT. Nasal cartilage visualization was feasible on the micro-CT compared with pathologic findings. Future research may further examine the barriers to accurately visualizing upper lateral cartilage and lower lateral cartilage, a prerequisite for clinical application.</p><p><strong>Level of evidence: </strong>NA.</p>","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"237-243"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2018.1931","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36938012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Role of Tranexamic Acid in Reducing Intraoperative Blood Loss and Postoperative Edema and Ecchymosis in Primary Elective Rhinoplasty: A Systematic Review and Meta-analysis. 氨甲环酸在初次择期鼻整形术中减少术中出血量和术后水肿及瘀斑中的作用:一项系统综述和荟萃分析。
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2018.1737
Connor McGuire, Sean Nurmsoo, Osama A Samargandi, Michael Bezuhly

Importance: Blood loss from surgical procedures is a major issue worldwide as the demand for blood products is increasing. Tranexamic acid is an antifibrinolytic agent commonly used to reduce intraoperative blood loss.

Objective: To systematically examine the role of tranexamic acid in reducing intraoperative blood loss and postoperative edema and ecchymosis among patients undergoing primary elective rhinoplasty.

Data sources: A systematic review and meta-analysis was undertaken in an academic medical setting using Medline, Embase, and Google Scholar from inception to June 30, 2018. All references of included articles were screened for potential inclusion. The search was mapped to Medical Subject Headings, and the following terms were used to identify potential articles: reconstruction or rhinoplasty and tranexamic acid or anti-fibrinolysis or antifibrinolysis and bleeding or ecchymosis or bruising or edema or complications.

Study selection: The population of interest consisted of adult patients undergoing primary elective rhinoplasty. The intervention was the use of tranexamic acid. The control group was composed of patients receiving a placebo. Primary outcomes were intraoperative blood loss and postoperative edema and ecchymosis. In vitro or animal studies were excluded, and only English-language articles were included.

Data extraction and synthesis: The PRISMA guidelines were followed, and articles were assessed using the Cochrane Collaboration's tool for assessing risk of bias and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. Random-effects meta-analysis was performed to determine the overall effect size.

Main outcomes and measures: The primary outcomes were intraoperative blood loss and postoperative edema and ecchymosis.

Results: Five studies (comprising 332 patients) were included in the qualitative analysis, all of which were randomized clinical trials published within the past 5 years. The mean (SD) patient age was 27 (7) years (age range, 16-42 years), while the mean (SD) sample size was 66 (19) (range, 50-96). Meta-analysis of 4 studies (271 patients) indicated that tranexamic acid treatment resulted in a mean reduction in intraoperative blood loss of -41.6 mL (95% CI, -69.8 to -13.4 mL) compared with controls (P = .004). Three studies indicated that postoperative edema and ecchymosis were reduced with tranexamic acid treatment compared with controls; however, there was no significant difference compared with corticosteroid use. Four studies were considered of high methodological quality, with a low risk of bias. The overall quality of evidence was high.

Conclusions and relevance: Tranexamic acid has the ability to significantly reduce intraoperative blood loss and postoperative edema and ecchymosis among patients

重要性:随着对血液制品的需求不断增加,外科手术失血是世界范围内的一个主要问题。氨甲环酸是一种抗纤溶剂,常用于减少术中失血。目的:系统探讨氨甲环酸在初次择期鼻整形术中减少术中出血量和术后水肿瘀斑的作用。数据来源:从开始到2018年6月30日,使用Medline、Embase和Google Scholar在学术医疗环境中进行了系统评价和荟萃分析。对纳入文章的所有参考文献进行筛选,以确定是否可能纳入。搜索被映射到医学主题标题,并使用以下术语来识别潜在的文章:重建或鼻整形和氨甲环酸或抗纤溶或抗纤溶和出血或瘀斑或挫伤或水肿或并发症。研究选择:研究对象包括接受初级择期鼻整形手术的成年患者。干预措施是使用氨甲环酸。对照组由服用安慰剂的患者组成。主要结局是术中失血和术后水肿和瘀斑。排除体外或动物研究,仅纳入英文文章。数据提取和综合:遵循PRISMA指南,使用Cochrane协作的偏倚风险评估工具和推荐评估、发展和评估分级(GRADE)指南对文章进行评估。随机效应荟萃分析确定总体效应大小。主要观察指标:主要观察指标为术中出血量和术后水肿瘀斑。结果:定性分析纳入5项研究(共332例患者),均为近5年内发表的随机临床试验。患者平均年龄(SD)为27(7)岁(年龄范围16-42岁),平均样本量(SD)为66(19)岁(年龄范围50-96)。4项研究(271例患者)的荟萃分析表明,与对照组相比,氨甲环酸治疗导致术中出血量平均减少-41.6 mL (95% CI, -69.8至-13.4 mL) (P = 0.004)。三项研究表明,与对照组相比,氨甲环酸治疗可减轻术后水肿和瘀斑;然而,与皮质类固醇的使用相比,没有显著差异。四项研究被认为具有高方法学质量,偏倚风险低。证据的总体质量很高。结论及意义:氨甲环酸能够显著减少初次择期鼻整形患者术中出血量和术后水肿瘀斑。证据等级:4。
{"title":"Role of Tranexamic Acid in Reducing Intraoperative Blood Loss and Postoperative Edema and Ecchymosis in Primary Elective Rhinoplasty: A Systematic Review and Meta-analysis.","authors":"Connor McGuire,&nbsp;Sean Nurmsoo,&nbsp;Osama A Samargandi,&nbsp;Michael Bezuhly","doi":"10.1001/jamafacial.2018.1737","DOIUrl":"https://doi.org/10.1001/jamafacial.2018.1737","url":null,"abstract":"<p><strong>Importance: </strong>Blood loss from surgical procedures is a major issue worldwide as the demand for blood products is increasing. Tranexamic acid is an antifibrinolytic agent commonly used to reduce intraoperative blood loss.</p><p><strong>Objective: </strong>To systematically examine the role of tranexamic acid in reducing intraoperative blood loss and postoperative edema and ecchymosis among patients undergoing primary elective rhinoplasty.</p><p><strong>Data sources: </strong>A systematic review and meta-analysis was undertaken in an academic medical setting using Medline, Embase, and Google Scholar from inception to June 30, 2018. All references of included articles were screened for potential inclusion. The search was mapped to Medical Subject Headings, and the following terms were used to identify potential articles: reconstruction or rhinoplasty and tranexamic acid or anti-fibrinolysis or antifibrinolysis and bleeding or ecchymosis or bruising or edema or complications.</p><p><strong>Study selection: </strong>The population of interest consisted of adult patients undergoing primary elective rhinoplasty. The intervention was the use of tranexamic acid. The control group was composed of patients receiving a placebo. Primary outcomes were intraoperative blood loss and postoperative edema and ecchymosis. In vitro or animal studies were excluded, and only English-language articles were included.</p><p><strong>Data extraction and synthesis: </strong>The PRISMA guidelines were followed, and articles were assessed using the Cochrane Collaboration's tool for assessing risk of bias and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. Random-effects meta-analysis was performed to determine the overall effect size.</p><p><strong>Main outcomes and measures: </strong>The primary outcomes were intraoperative blood loss and postoperative edema and ecchymosis.</p><p><strong>Results: </strong>Five studies (comprising 332 patients) were included in the qualitative analysis, all of which were randomized clinical trials published within the past 5 years. The mean (SD) patient age was 27 (7) years (age range, 16-42 years), while the mean (SD) sample size was 66 (19) (range, 50-96). Meta-analysis of 4 studies (271 patients) indicated that tranexamic acid treatment resulted in a mean reduction in intraoperative blood loss of -41.6 mL (95% CI, -69.8 to -13.4 mL) compared with controls (P = .004). Three studies indicated that postoperative edema and ecchymosis were reduced with tranexamic acid treatment compared with controls; however, there was no significant difference compared with corticosteroid use. Four studies were considered of high methodological quality, with a low risk of bias. The overall quality of evidence was high.</p><p><strong>Conclusions and relevance: </strong>Tranexamic acid has the ability to significantly reduce intraoperative blood loss and postoperative edema and ecchymosis among patients","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"191-198"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2018.1737","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36830290","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
Dual Nerve Transfer for Facial Reanimation. 双神经移植用于面部恢复。
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2019.0001
Jon-Paul Pepper
{"title":"Dual Nerve Transfer for Facial Reanimation.","authors":"Jon-Paul Pepper","doi":"10.1001/jamafacial.2019.0001","DOIUrl":"https://doi.org/10.1001/jamafacial.2019.0001","url":null,"abstract":"","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"260-261"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2019.0001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37033003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
A Practical Guide to Managing Body Dysmorphic Disorder in the Cosmetic Surgery Setting. 在整容手术中处理身体畸形障碍的实用指南。
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2018.1840
Jennifer L Greenberg, Hilary Weingarden, Sabine Wilhelm
{"title":"A Practical Guide to Managing Body Dysmorphic Disorder in the Cosmetic Surgery Setting.","authors":"Jennifer L Greenberg,&nbsp;Hilary Weingarden,&nbsp;Sabine Wilhelm","doi":"10.1001/jamafacial.2018.1840","DOIUrl":"https://doi.org/10.1001/jamafacial.2018.1840","url":null,"abstract":"","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"181-182"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2018.1840","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36893048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis. 面部联动性患者肉毒杆菌治疗的治疗模式和结果。
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2018.1962
Justin R Shinn, Nkechi N Nwabueze, Liping Du, Priyesh N Patel, Kevin K Motamedi, Cathey Norton, William R Ries, Scott J Stephan

Importance: In the last decade, there has been a significant increase in the number of practitioners administering botulinum toxin for facial synkinesis. However, there are few resources available to guide treatment patterns, and little is known about how these patterns are associated with functional outcomes and quality of life.

Objective: To evaluate botulinum treatment patterns, including the dosing and frequency of muscle targeting, for treatment of facial synkinesis and to quantify patient outcomes.

Design, setting, and participants: This prospective cohort study of 99 patients treated for facial synkinesis was conducted from January 2016 through December 2018 at the Vanderbilt Bill Wilkerson Center in Nashville, Tennessee, a tertiary referral center.

Intervention: Onabotulinum toxin A treatment of facial synkinesis.

Main outcomes and measures: Patient-reported outcomes on the Synkinesis Assessment Questionnaire and botulinum treatment patterns, including the dosages and frequency of injection for each facial muscle, were compared at the initiation of treatment and at the end of recorded treatment.

Results: In total, 99 patients (80 female patients [81%]) underwent botulinum injections for treatment of facial synkinesis. The median (interquartile range) age was 54.0 (43.5-61.5) years, and the median (interquartile range) follow-up was 27.1 (8.9-59.7) months. Most patients underwent injections after receiving a diagnosis of Bell palsy (41 patients, 41%) or after resection of vestibular schwannoma (36 patients [36%]). The patients received a total of 441 treatment injections, and 369 pretreatment and posttreatment Synkinesis Assessment Questionnaire scores were analyzed. The mean botulinum dose was 2 to 3 U for each facial muscle and 9 to 10 U for the platysma muscle. The dose increased over time for the majority of all muscles, with steady state achieved after a median of 3 treatments (interquartile range, 2-3). Linear regression analysis for cluster data of the mean total questionnaire score difference was -14.2 (95% CI, -17.0 to -11.5; P < .001). There was a significant association of postinjection questionnaire score with younger patients, female sex, total dose, and synkinesis severity. Oculo-oral synkinesis may respond more to treatment compared with oro-ocular synkinesis.

Conclusion and relevance: Patients with facial synkinesis responded significantly to botulinum treatment. Treatment began with 6 core facial muscles that were injected during most treatment sessions, and dosages increased after the first injection until steady state was achieved. Those with a greater degree of morbidity, younger patients, and females showed significant improvement, and the larger the dose administered, the greater the response. Oculo-oral synkinesis may be more responsive than oro-ocular synkinesi

重要性:在过去的十年中,有显着增加的从业人员施用肉毒杆菌毒素面部联动性。然而,指导治疗模式的资源很少,而且这些模式与功能结果和生活质量之间的关系也知之甚少。目的:评价肉毒杆菌治疗面部联动性的治疗模式,包括剂量和肌肉靶向频率,并量化患者的结果。设计、环境和参与者:这项前瞻性队列研究于2016年1月至2018年12月在田纳西州纳什维尔的范德比尔·威尔克森中心进行,该中心是三级转诊中心。干预:A型肉毒杆菌毒素治疗面瘫。主要结局和措施:比较患者在联动性评估问卷上报告的结局和肉毒杆菌治疗模式,包括治疗开始和治疗结束时记录的每一块面部肌肉的注射剂量和频率。结果:99例患者(女性80例,占81%)接受肉毒杆菌注射治疗面瘫。年龄中位数(四分位数间距)为54.0(43.5-61.5)岁,随访时间中位数(四分位数间距)27.1(8.9-59.7)个月。大多数患者在诊断为贝尔麻痹(41例,41%)或前庭神经鞘瘤切除术(36例,36%)后接受注射。患者共接受441次治疗注射,分析369次治疗前后联动性评价问卷得分。每条面部肌肉的肉毒杆菌平均剂量为2 ~ 3u,阔阔肌的肉毒杆菌平均剂量为9 ~ 10u。大多数肌肉的剂量随着时间的推移而增加,中位数为3次治疗后达到稳定状态(四分位数范围为2-3)。线性回归分析聚类资料的问卷总分平均差值为-14.2 (95% CI, -17.0 ~ -11.5;结论及意义:面部联动性患者对肉毒杆菌治疗有显著反应。治疗开始于6块面部核心肌肉,在大多数治疗期间注射,并在第一次注射后增加剂量,直到达到稳定状态。那些发病率较高的患者、年轻患者和女性患者表现出显著的改善,并且给予的剂量越大,反应越大。眼-口联动可能比眼-眼联动反应更灵敏。证据等级:3。
{"title":"Treatment Patterns and Outcomes in Botulinum Therapy for Patients With Facial Synkinesis.","authors":"Justin R Shinn,&nbsp;Nkechi N Nwabueze,&nbsp;Liping Du,&nbsp;Priyesh N Patel,&nbsp;Kevin K Motamedi,&nbsp;Cathey Norton,&nbsp;William R Ries,&nbsp;Scott J Stephan","doi":"10.1001/jamafacial.2018.1962","DOIUrl":"https://doi.org/10.1001/jamafacial.2018.1962","url":null,"abstract":"<p><strong>Importance: </strong>In the last decade, there has been a significant increase in the number of practitioners administering botulinum toxin for facial synkinesis. However, there are few resources available to guide treatment patterns, and little is known about how these patterns are associated with functional outcomes and quality of life.</p><p><strong>Objective: </strong>To evaluate botulinum treatment patterns, including the dosing and frequency of muscle targeting, for treatment of facial synkinesis and to quantify patient outcomes.</p><p><strong>Design, setting, and participants: </strong>This prospective cohort study of 99 patients treated for facial synkinesis was conducted from January 2016 through December 2018 at the Vanderbilt Bill Wilkerson Center in Nashville, Tennessee, a tertiary referral center.</p><p><strong>Intervention: </strong>Onabotulinum toxin A treatment of facial synkinesis.</p><p><strong>Main outcomes and measures: </strong>Patient-reported outcomes on the Synkinesis Assessment Questionnaire and botulinum treatment patterns, including the dosages and frequency of injection for each facial muscle, were compared at the initiation of treatment and at the end of recorded treatment.</p><p><strong>Results: </strong>In total, 99 patients (80 female patients [81%]) underwent botulinum injections for treatment of facial synkinesis. The median (interquartile range) age was 54.0 (43.5-61.5) years, and the median (interquartile range) follow-up was 27.1 (8.9-59.7) months. Most patients underwent injections after receiving a diagnosis of Bell palsy (41 patients, 41%) or after resection of vestibular schwannoma (36 patients [36%]). The patients received a total of 441 treatment injections, and 369 pretreatment and posttreatment Synkinesis Assessment Questionnaire scores were analyzed. The mean botulinum dose was 2 to 3 U for each facial muscle and 9 to 10 U for the platysma muscle. The dose increased over time for the majority of all muscles, with steady state achieved after a median of 3 treatments (interquartile range, 2-3). Linear regression analysis for cluster data of the mean total questionnaire score difference was -14.2 (95% CI, -17.0 to -11.5; P < .001). There was a significant association of postinjection questionnaire score with younger patients, female sex, total dose, and synkinesis severity. Oculo-oral synkinesis may respond more to treatment compared with oro-ocular synkinesis.</p><p><strong>Conclusion and relevance: </strong>Patients with facial synkinesis responded significantly to botulinum treatment. Treatment began with 6 core facial muscles that were injected during most treatment sessions, and dosages increased after the first injection until steady state was achieved. Those with a greater degree of morbidity, younger patients, and females showed significant improvement, and the larger the dose administered, the greater the response. Oculo-oral synkinesis may be more responsive than oro-ocular synkinesi","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"244-251"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2018.1962","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36963727","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 37
Association Between the Thickness, Width, Initial Curvature, and Graft Origin of Costal Cartilage and Its Warping Characteristics. 肋软骨厚度、宽度、初始曲率和移植物来源及其翘曲特征之间的关系。
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2018.2093
Amir A Hakimi, Allen Foulad, Kevin Ganesh, Brian J F Wong
This study compares the degree of warping in costal cartilage specimens having different thicknesses, widths, initial curvatures, and origin relative to the central cross-section.
{"title":"Association Between the Thickness, Width, Initial Curvature, and Graft Origin of Costal Cartilage and Its Warping Characteristics.","authors":"Amir A Hakimi,&nbsp;Allen Foulad,&nbsp;Kevin Ganesh,&nbsp;Brian J F Wong","doi":"10.1001/jamafacial.2018.2093","DOIUrl":"https://doi.org/10.1001/jamafacial.2018.2093","url":null,"abstract":"This study compares the degree of warping in costal cartilage specimens having different thicknesses, widths, initial curvatures, and origin relative to the central cross-section.","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"262-263"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2018.2093","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37009149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Neovascularization Perfusion of Melolabial Flaps Using Intraoperative Indocyanine Green Angiography. 术中吲哚菁绿血管造影在唇瓣新生血管灌注中的应用。
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2018.1874
Mohamed Abdelwahab, Emily A Spataro, Cherian K Kandathil, Sam P Most

Importance: Assessment of melolabial flap perfusion using indocyanine green (ICG) angiography for nasal reconstruction has not been previously described.

Objective: To assess melolabial flap relative perfusion using ICG angiography in nasal reconstruction and highlight its clinical relevance.

Design, setting, and participants: In this retrospective case series at a tertiary referral center, 10 patients undergoing melolabial flap reconstruction of nasal defects between January 2015 to April 2018 with flap perfusion were assessed by ICG angiography.

Exposures: Indocyanine green angiography was performed to assess melolabial flap perfusion at second stage surgery after temporary clamping of the pedicle and after pedicle division and flap inset.

Main outcomes and measures: Flap perfusion in relation to a reference point on the cheek was calculated after both pedicle clamping and division by 2 methods: (1) ingress (arterial inflow) and egress (venous outflow) flap-to-cheek ratio; (2) flap-to-cheek perfusion (fluorescence) ratio at 3 time points (midpoint of ICG flap inflow, maximum [peak] fluorescence, and midpoint of ICG outflow), and their calculated mean. Correlations of perfusion with time between stages, and patient factors were performed; perfusion parameters after temporary pedicle clamping and after division and flap inset were compared.

Results: Ten patients (mean [SD] age, 66 [7.5] years) were enrolled with a mean (SD) interval of 23 (4) days between first and second surgery. No correlation existed between perfusion parameters and time interval between first and second stage, or any other patient factors. Of the different perfusion parameters, a statistically significant difference was observed when comparing temporary clamping and postdivision mean (SD) flap-to-cheek perfusion ratio (0.89 [0.22] and 0.80 [0.19]; 95% CI, 4.1-12.6; P = .001), as well as mean (SD) peak perfusion ratio (0.81 [0.2] and 0.77 [0.2]; 95% CI, 0.005-0.080; P = .02) only. No partial or complete flap necrosis was reported after pedicle division.

Conclusions and relevance: Indocyanine green angiography is an effective method to determine neovascularization perfusion of melolabial flaps, with a mean perfusion of 89% after pedicle clamping. Future applications of this technology include use in patients at high risk for flap necrosis, or those who may benefit from early flap division to ensure adequate perfusion and minimize the time interval between staged procedures.

Level of evidence: NA.

重要性:使用吲哚菁绿(ICG)血管造影术评估鼻重建的唇瓣灌注尚未有报道。目的:探讨ICG血管造影在鼻部再造术中的应用价值及临床意义。设计、环境和参与者:在该三级转诊中心的回顾性病例系列中,2015年1月至2018年4月期间,10例患者接受唇瓣鼻部缺损重建,皮瓣灌注通过ICG血管造影进行评估。暴露:在临时夹紧椎弓根和椎弓根分割并置入皮瓣后的第二期手术中,采用吲哚菁绿血管造影评估踝瓣的灌注情况。主要结果和措施:通过2种方法(1)入口(动脉流入)和出口(静脉流出)皮瓣与脸颊的比值,计算皮瓣夹紧和分割后与脸颊参考点相关的血流灌注;(2) 3个时间点(ICG皮瓣流入中点、最大荧光[峰]点、ICG流出中点)皮瓣-颊灌注(荧光)比及其计算平均值。观察灌注与分期间时间和患者因素的相关性;比较临时椎弓根夹紧后与分割皮瓣置入后的灌注参数。结果:纳入10例患者(平均[SD]年龄66[7.5]岁),第一次和第二次手术的平均(SD)间隔为23(4)天。灌注参数与一、二期时间间隔及其他患者因素均无相关性。在不同的灌注参数中,比较临时夹持和术后皮瓣与面颊的平均灌注比(SD),差异有统计学意义(0.89[0.22]和0.80 [0.19]);95% ci, 4.1-12.6;P = .001),平均(SD)峰值灌注比分别为0.81[0.2]和0.77 [0.2];95% ci, 0.005-0.080;P = .02)。蒂分裂后皮瓣未见部分或完全坏死。结论及意义:吲哚菁绿血管造影是测定唇瓣新生血管灌注的有效方法,夹根后平均灌注为89%。该技术的未来应用包括用于皮瓣坏死高风险的患者,或那些可能受益于早期皮瓣分裂以确保足够的灌注并缩短分阶段手术之间的时间间隔的患者。证据等级:NA。
{"title":"Neovascularization Perfusion of Melolabial Flaps Using Intraoperative Indocyanine Green Angiography.","authors":"Mohamed Abdelwahab,&nbsp;Emily A Spataro,&nbsp;Cherian K Kandathil,&nbsp;Sam P Most","doi":"10.1001/jamafacial.2018.1874","DOIUrl":"https://doi.org/10.1001/jamafacial.2018.1874","url":null,"abstract":"<p><strong>Importance: </strong>Assessment of melolabial flap perfusion using indocyanine green (ICG) angiography for nasal reconstruction has not been previously described.</p><p><strong>Objective: </strong>To assess melolabial flap relative perfusion using ICG angiography in nasal reconstruction and highlight its clinical relevance.</p><p><strong>Design, setting, and participants: </strong>In this retrospective case series at a tertiary referral center, 10 patients undergoing melolabial flap reconstruction of nasal defects between January 2015 to April 2018 with flap perfusion were assessed by ICG angiography.</p><p><strong>Exposures: </strong>Indocyanine green angiography was performed to assess melolabial flap perfusion at second stage surgery after temporary clamping of the pedicle and after pedicle division and flap inset.</p><p><strong>Main outcomes and measures: </strong>Flap perfusion in relation to a reference point on the cheek was calculated after both pedicle clamping and division by 2 methods: (1) ingress (arterial inflow) and egress (venous outflow) flap-to-cheek ratio; (2) flap-to-cheek perfusion (fluorescence) ratio at 3 time points (midpoint of ICG flap inflow, maximum [peak] fluorescence, and midpoint of ICG outflow), and their calculated mean. Correlations of perfusion with time between stages, and patient factors were performed; perfusion parameters after temporary pedicle clamping and after division and flap inset were compared.</p><p><strong>Results: </strong>Ten patients (mean [SD] age, 66 [7.5] years) were enrolled with a mean (SD) interval of 23 (4) days between first and second surgery. No correlation existed between perfusion parameters and time interval between first and second stage, or any other patient factors. Of the different perfusion parameters, a statistically significant difference was observed when comparing temporary clamping and postdivision mean (SD) flap-to-cheek perfusion ratio (0.89 [0.22] and 0.80 [0.19]; 95% CI, 4.1-12.6; P = .001), as well as mean (SD) peak perfusion ratio (0.81 [0.2] and 0.77 [0.2]; 95% CI, 0.005-0.080; P = .02) only. No partial or complete flap necrosis was reported after pedicle division.</p><p><strong>Conclusions and relevance: </strong>Indocyanine green angiography is an effective method to determine neovascularization perfusion of melolabial flaps, with a mean perfusion of 89% after pedicle clamping. Future applications of this technology include use in patients at high risk for flap necrosis, or those who may benefit from early flap division to ensure adequate perfusion and minimize the time interval between staged procedures.</p><p><strong>Level of evidence: </strong>NA.</p>","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"230-236"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2018.1874","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36937472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
Opioid Prescription Patterns After Rhinoplasty-Reply. 鼻整形后阿片类药物处方模式的回复。
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2018.1747
Rosh K V Sethi, Linda N Lee, David A Shaye
{"title":"Opioid Prescription Patterns After Rhinoplasty-Reply.","authors":"Rosh K V Sethi,&nbsp;Linda N Lee,&nbsp;David A Shaye","doi":"10.1001/jamafacial.2018.1747","DOIUrl":"https://doi.org/10.1001/jamafacial.2018.1747","url":null,"abstract":"","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"264"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2018.1747","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"37009155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors Associated With Complications After Treatment of Mandible Fractures. 下颌骨骨折治疗后并发症的相关危险因素。
Q1 Medicine Pub Date : 2019-05-01 DOI: 10.1001/jamafacial.2018.1836
Tsung-Yen Hsieh, Jamie L Funamura, Raj Dedhia, Blythe Durbin-Johnson, Chance Dunbar, Travis T Tollefson

Importance: Complications that arise after treatment of mandible fractures can result in significant morbidity. Identifying modifiable risk factors associated with these complications is valuable in guiding clinical practice for improved patient outcomes.

Objective: To describe the risk factors associated with complications in patients undergoing treatment for mandible fracture.

Design, setting, and participants: A retrospective review was conducted of 137 patients presenting to a tertiary care, level 1 trauma center with mandible fractures between January 1, 2014, and January 1, 2017. Outcomes and demographic characteristics for patients with at least 3 weeks of follow-up were compared using multivariate logistic regression analysis.

Results: Of the 137 patients meeting inclusion criteria, there were 113 males (82.5%) and 24 females (17.5%), with a mean (SD) age at presentation of 32.3 (15.7) years. Median follow-up was 71 days (range, 22-1189 days). Postoperative complications were identified in 29 patients (21.2%); complications included wound dehiscence or surgical site infection (n = 17), bony nonunion (n = 5), and hardware exposure (n = 13). Complications were managed surgically in 19 patients and nonsurgically in 10 patients. On univariate analysis, the initial surgery was completed later (mean [SD], 5.9 [6.6] days after injury) in patients who developed complications than in those who did not (mean [SD], 3.8 [4.0] days). On multivariate analysis, complications were associated with increased time from injury to treatment (odds ratio [OR], 1.60; 95% CI, 1.02-2.53; P = .04), tobacco use (OR, 8.10; 95% CI, 1.26-52.00; P = .03), and dental extraction (OR, 93.00; 95% CI, 1.19 to >999.00; P = .04). Residence in the same city as the medical center was associated with fewer complications (OR, 0.08; 95% CI, 0.01-0.69; P = .02).

Conclusions and relevance: In a 3-year review of mandible fractures managed at a single academic center, complications were associated with an increased time to treatment, tobacco use, dental extraction, and living farther from the treatment facility. On a systems level, the results of this study suggest that expediting intervention for mandible fractures may improve outcomes.

Level of evidence: 3.

重要性:下颌骨骨折治疗后出现的并发症可导致显著的发病率。确定与这些并发症相关的可改变的危险因素对于指导临床实践以改善患者预后是有价值的。目的:探讨下颌骨骨折患者并发症的相关危险因素。设计、环境和参与者:对2014年1月1日至2017年1月1日期间在三级护理1级创伤中心就诊的137例下颌骨骨折患者进行回顾性分析。采用多因素logistic回归分析比较随访至少3周患者的结局和人口学特征。结果:137例符合纳入标准的患者中,男性113例(82.5%),女性24例(17.5%),平均(SD)发病年龄为32.3(15.7)岁。中位随访71天(范围22-1189天)。术后并发症29例(21.2%);并发症包括伤口裂开或手术部位感染(n = 17),骨不连(n = 5)和硬体暴露(n = 13)。并发症19例手术处理,10例非手术处理。单因素分析显示,出现并发症的患者比未出现并发症的患者(平均[SD], 3.8[4.0]天)更晚完成初始手术(平均[SD],损伤后5.9[6.6]天)。在多变量分析中,并发症与从受伤到治疗的时间增加有关(优势比[OR], 1.60;95% ci, 1.02-2.53;P = .04),烟草使用(OR, 8.10;95% ci, 1.26-52.00;P = .03),拔牙(OR, 93.00;95% CI, 1.19至>999.00;p = .04)。居住在医疗中心所在城市的患者并发症发生率较低(OR, 0.08;95% ci, 0.01-0.69;p = .02)。结论和相关性:在一个学术中心进行的一项为期3年的下颌骨骨折治疗回顾中,并发症与治疗时间延长、吸烟、拔牙和居住距离治疗设施较远有关。在系统水平上,本研究的结果表明,加快对下颌骨骨折的干预可能会改善预后。证据等级:3。
{"title":"Risk Factors Associated With Complications After Treatment of Mandible Fractures.","authors":"Tsung-Yen Hsieh,&nbsp;Jamie L Funamura,&nbsp;Raj Dedhia,&nbsp;Blythe Durbin-Johnson,&nbsp;Chance Dunbar,&nbsp;Travis T Tollefson","doi":"10.1001/jamafacial.2018.1836","DOIUrl":"https://doi.org/10.1001/jamafacial.2018.1836","url":null,"abstract":"<p><strong>Importance: </strong>Complications that arise after treatment of mandible fractures can result in significant morbidity. Identifying modifiable risk factors associated with these complications is valuable in guiding clinical practice for improved patient outcomes.</p><p><strong>Objective: </strong>To describe the risk factors associated with complications in patients undergoing treatment for mandible fracture.</p><p><strong>Design, setting, and participants: </strong>A retrospective review was conducted of 137 patients presenting to a tertiary care, level 1 trauma center with mandible fractures between January 1, 2014, and January 1, 2017. Outcomes and demographic characteristics for patients with at least 3 weeks of follow-up were compared using multivariate logistic regression analysis.</p><p><strong>Results: </strong>Of the 137 patients meeting inclusion criteria, there were 113 males (82.5%) and 24 females (17.5%), with a mean (SD) age at presentation of 32.3 (15.7) years. Median follow-up was 71 days (range, 22-1189 days). Postoperative complications were identified in 29 patients (21.2%); complications included wound dehiscence or surgical site infection (n = 17), bony nonunion (n = 5), and hardware exposure (n = 13). Complications were managed surgically in 19 patients and nonsurgically in 10 patients. On univariate analysis, the initial surgery was completed later (mean [SD], 5.9 [6.6] days after injury) in patients who developed complications than in those who did not (mean [SD], 3.8 [4.0] days). On multivariate analysis, complications were associated with increased time from injury to treatment (odds ratio [OR], 1.60; 95% CI, 1.02-2.53; P = .04), tobacco use (OR, 8.10; 95% CI, 1.26-52.00; P = .03), and dental extraction (OR, 93.00; 95% CI, 1.19 to >999.00; P = .04). Residence in the same city as the medical center was associated with fewer complications (OR, 0.08; 95% CI, 0.01-0.69; P = .02).</p><p><strong>Conclusions and relevance: </strong>In a 3-year review of mandible fractures managed at a single academic center, complications were associated with an increased time to treatment, tobacco use, dental extraction, and living farther from the treatment facility. On a systems level, the results of this study suggest that expediting intervention for mandible fractures may improve outcomes.</p><p><strong>Level of evidence: </strong>3.</p>","PeriodicalId":14538,"journal":{"name":"JAMA facial plastic surgery","volume":"21 3","pages":"213-220"},"PeriodicalIF":0.0,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1001/jamafacial.2018.1836","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36892603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 28
期刊
JAMA facial plastic surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1